Recall notices were issued by the Food and Drug Administration (FDA) on Friday for two brands of Japanese seirogan, a common antidiarrheal drug in Taiwan, informing people that 20 million pills produced in eight batches are to be recalled due to deviations from the drug's specifications.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
Amazon expands Asia-Pacific web services with Taiwan
06/06/2025 04:47 PM - Business
U.S. dollar closes higher on Taipei forex market
06/06/2025 04:25 PM - Society
Spanish tourist jumps from moving car as driver flees airport police
06/06/2025 03:24 PM - Society
Tropical disturbance may become 1st typhoon in 2025: CWA
06/06/2025 02:31 PM - Society
Taipei Zoo to be closed for 10 days from June 18
06/06/2025 02:13 PM